Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs
Insights from Prof. Timothy Baily on new Real-world evidence in deliver G study and the implications of adding Toujeo® to people with T2D inadequately controlled on GLP-RAs.
.jpg5/jcr:content/image%20(29).jpg)
.jpg/jcr:content/The-value-of-time-in-range%20(1).jpg)
MAT-BH-2300616/v1/November 2023